Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus
Sign Up to like & getrecommendations! Published in 2021 at "Annals of Internal Medicine"
DOI: 10.7326/m21-2078
Abstract: BACKGROUND B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We hypothesized that high B-cell activating factor (BAFF) levels… read more here.
Keywords: lupus erythematosus; sle refractory; belimumab rituximab; systemic lupus ... See more keywords